Brazier Stuart Damon purchased $44K of AIIR

Brazier Stuart Damon (Chief Executive Officer) purchased 6,000 shares of AIR Global PLC (AIIR) at $7.35 on 2026-08-27.

Original reporting
SEC EDGAR · Brazier Stuart Damon
Published Sep 1, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 8:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$AIIR
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

The purchase is a primary disclosure but modest in scale.

02

Market read

Small insider purchase with limited trading relevance.

03

What to watch

Potential upcoming corporate actions not disclosed.

Relevance 4/10Novelty 5/10Timing: filed Sep 1, 2026

Background

Form 4 filing reports insider transactions required by SEC.

Market effects

None

None

None

Counterpoint

Insider buying may be routine and not indicative of future performance.

Key entities

  • AIR Global PLC

    Issuer of the Form 4 filing.

  • Brazier Stuart Damon

    CEO and insider purchaser.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIIRLow

AIR Global PLC (AIIR): Financial results for H1 2026

AIR Global PLC (AIIR) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 PRESS RELEASE AIR GLOBAL PLC. AIR Global Reports 2026 First-Half Results Revenue increased 3.7% to $206.9 million despite Strait of Hormuz disruptions Adjusted EBITDA remained stable yoy at $71.7 million Expects accelerating growth in the second half of 2026 DUBAI, U

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).